Testing thinking and learning in congenital central hypoventilation syndrome
Part of Brain & nervous system, Lungs & breathing clinical trials.
This study looks at thinking and memory in people with congenital central hypoventilation syndrome (CCHS) to better understand how the condition affects the brain. It may help researchers measure changes over time and guide future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a CCHS diagnosis confirmed by a PHOX2B gene test
- You can speak English as your main language
- You can read English as your main language
- You should not be unsure about your CCHS diagnosis—you need confirmation
- You should not join if English speaking/reading is not your primary language
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study creates a secure health information hub for people with Congenital Central Hypoventilation Syndrome (CCHS) to help researchers better understand the condition and find new ways to treat it. Being part of this hub may help advance future studies and care options for CCHS.
This study is a registry, meaning it collects health information to better understand congenital central hypoventilation syndrome (CCHS). It enrolls only people whose CCHS has been confirmed by a PHOX2B gene test.
This study is looking for biomarkers (biological clues) in blood and urine that could help doctors understand CCHS better and improve care. It involves giving a small sample of blood and urine, and is open to adults with CCHS who use a ventilator at night.
This trial studies how children’s thinking and learning skills change while they receive proton beam radiation for a brain/spinal cord tumor. It uses computer-based cognitive tests to better understand brain effects during treatment, which may help future care.
This study tests new ways to measure thinking and memory skills in people with Huntington's disease. It aims to find better tools for tracking the disease and could help you understand your cognitive changes.
This study looks at how brain tumors and their treatments affect memory, thinking, and daily function. It aims to understand these effects to better support patients.
Hear when a new Congenital Central Hypoventilation Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.